Related Experiment Video
Updated: Jul 17, 2026
10:22
Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
Published on: September 16, 2011
[Guidelines for health-economic evaluations in Austria]
Evelyn Walter1, Susanne Zehetmayr
1Institut für Pharmaökonomische Forschung, Wien, Osterreich. ipf@ipf-ac.at
Wiener Medizinische Wochenschrift (1946)
|January 11, 2007
Summary
New guidelines for health-economic evaluations in Austria aim to standardize decision-making for innovative health technologies. These standards support policymakers in navigating uncertainty and financial constraints in healthcare.
Area of Science:
- Health Economics
- Health Technology Assessment
Background:
- Evaluative health economics is a growing field crucial for policy decisions.
- Increasing use of innovative health technologies presents financial challenges in healthcare.
- Systematic analytical tools are essential for informed decision-making under uncertainty.
Purpose of the Study:
- To establish guidelines for health-economic evaluations in Austria.
- To ensure transparent and valid interpretation of health-economic evaluation results.
- To balance standardization with scientific freedom in health economics research.
Main Methods:
- Development of guidelines for health-economic evaluations.
- Emphasis on state-of-the-art methodology and transparency.
- Inclusion of standards for decision-making processes.
Main Results:
- Guidelines provide a framework for cost-effectiveness decisions.
- Standards aim to improve systematic decision-making.
- Methodological transparency is a key component.
Conclusions:
- The establishment of health-economic evaluation guidelines represents a significant advancement for Austria.
- These guidelines will aid policymakers in managing healthcare resources effectively.
- The initiative supports evidence-based decision-making in the evolving landscape of health technologies.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:16Bioequivalence Data: Statistical Interpretation
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
01:20Study Designs in Epidemiology
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
01:30Health Information Technology and Healthcare Information System
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include: